16JUN

US widens Ebola ban to green-card holders

3 min read

10:26UTC

HHS extended its 30-day Ebola entry ban to green-card holders on 5 June, while the treaty annex meant to tie data-sharing to vaccine access stayed deadlocked ahead of July talks.

← Back to Bundibugyo's fork stays open Jump to analysis ↓

ScienceDeveloping

Key takeaway

DRC shares Bundibugyo sequence data now while the annex guaranteeing access stays deadlocked into July.

The US Department of Health and Human Services (HHS), the federal department overseeing the CDC, expanded its 30-day Ebola entry ban on 5 June to cover green-card holders, lawful permanent residents ¹. The restriction has been in force since 18 May against travellers from DRC, Uganda and South Sudan and runs to about 17 June, so it has widened rather than expired. DRC's health minister called it discriminatory and unsupported by science, and Kinshasa is negotiating an early lift ². A counter-case exists: states may reasonably screen at the border during an emergency, and a Ugandan traveller with a recent United Arab Emirates (UAE) history did surface in the case data, though the UAE confirmed on 3 June it had found no onward transmission ³.

The restriction lands while the treaty meant to govern moments like this stays stuck. The WHO Pandemic Agreement's Pathogen Access and Benefit-Sharing annex, PABS, the rule tying rapid pathogen-data sharing by source countries to guaranteed access to the vaccines and treatments derived from it, was deferred at the World Health Assembly and now waits on the seventh negotiating session, IGWG7 (the Intergovernmental Working Group), 6 to 17 July ⁴. WHO cannot open the agreement for signature until member states adopt the annex.

DRC shows the mechanism live right now. Kinshasa is sharing Bundibugyo sequence data in real time, the genome already confirmed distinct from the 2007 and 2012 strains, while receiving no treaty-guaranteed access to whatever those sequences help produce. DRC is paying into a system whose July deadline arrives months after the vaccines its data informs. The gap the annex exists to close is running live, in one country, this month.

Deep Analysis

In plain English

The US government imposed a travel ban in May on people from DRC, Uganda and South Sudan , three countries connected to this Ebola outbreak. On 5 June they expanded it to include green-card holders, meaning even people who live legally in the US and were travelling to those countries now face restrictions on returning. The World Health Organisation says travel bans don't stop Ebola , which needs direct contact with infected bodily fluids to spread , and actually make outbreaks worse by blocking health workers and disrupting supply chains. DRC's health minister called it discriminatory. Separately, a global treaty that was supposed to guarantee that countries like DRC get fair access to vaccines when they share disease data is still deadlocked in negotiations, with the next attempt scheduled for July.

Deep Analysis

Root Causes

The PABS deadlock has a structural root cause that predates the current outbreak: roughly 100 LMIC member states demand that rapid pathogen-data sharing be contractually linked to guaranteed access to vaccines and treatments derived from those sequences, while high-income bloc states, protecting pharmaceutical IP arrangements and open-sequence-data norms, have refused to make vaccine access legally binding.

DRC is currently demonstrating the LMIC position in real time: it shared Bundibugyo sequence data under existing surveillance norms, vaccine investment arrived via CEPI and GAVI, and DRC nationals simultaneously face a US entry ban.

The green-card expansion by HHS has a domestic legal root cause separate from the epidemiology: the 18 May order's original exclusion of lawful permanent residents was challenged on due-process grounds under the Fifth Amendment, and the expansion to include them likely reflects administration legal advice that the original order's carve-out was inconsistent with the public-health emergency rationale.

Escalation

The green-card expansion represents an escalation from the 18 May entry ban : extending to lawful permanent residents means the restriction now covers a class of people with established legal ties to the US, raising constitutional challenge risk and creating a stronger diplomatic friction point.

The ban's ~17 June expiry creates a near-term decision point: extend, allow to lapse, or replace with a monitoring framework. Kinshasa's active negotiation for early lifting suggests a deal on enhanced screening in lieu of the ban is the most probable outcome, but the outcome depends on outbreak trajectory over the next eight days.

What could happen next?

Risk
The PABS deadlock at IGWG7 (6-17 July) runs in parallel with the DRC outbreak: if July produces no text, the full WHO Pandemic Agreement cannot open for signature, and the current outbreak provides the clearest demonstration yet of the equity gap it was designed to close.
Short term · Assessed
Consequence
The entry ban's inclusion of green-card holders creates a constitutional challenge pathway and a diplomatic friction point with Kinshasa that may complicate US-led outbreak response coordination, including the US-led FIFA World Cup screening protocols announced 28 May.
Immediate · Assessed
Precedent
The PABS negotiating bloc's real-world illustration , DRC sharing sequence data, then facing a US travel ban , may harden LMIC positions at IGWG7 rather than create goodwill, making a July breakthrough less rather than more likely.
Short term · Assessed

Source Landscape

This story draws on mixed-leaning sources from United States

United States×2

Primary parallel: During the 2014-2016 West Africa Ebola epidemic, the US imposed a de facto travel restriction on Liberia, Sierra Leone, and Guinea nationals in October 2014 via enhanced screening at five airports, after CDC Director Tom Frieden and President Obama had both publicly opposed travel bans.

The congressional pressure that produced those measures came after the Dallas Thomas Eric Duncan case, which involved a Liberian national WHO entered the US on a tourist visa. The green-card extension in 2026 maps structurally onto that 2014 pattern: an initial screening framework escalated under domestic political pressure to cover a broader immigrant category.

Counter-parallel: Australia's 2014 travel ban on West African nations produced no documented reduction in transmission risk, as no travel-linked cases reached Australia during the epidemic. However, it demonstrably reduced the response capacity of aid organisations recruiting Australian health workers for the outbreak response , an operational cost that WHO documented and which informed the current IHR Temporary Recommendations framework.

Consensus view: Chatham House's Global Health Programme and the Johns Hopkins Center for Health Security both hold that travel restrictions on Ebola , which is not airborne and requires direct fluid contact for transmission , reduce surveillance capacity more than transmission risk.

Restricting lawful permanent residents (green-card holders) goes beyond any IHR framework precedent: the WHO Temporary Recommendations issued on 22 May explicitly advise against travel restrictions, and the IHR Emergency Committee did not recommend them. The WHO position is that screening and monitoring are sufficient and that restrictions impede humanitarian workers and cross-border responders.

Counter-view: The Trump administration's HHS framing reflects a domestic political logic that the prior 18 May restriction had already established: demonstrating border control over a health threat has a domestic audience independent of epidemiological justification.

DRC's health minister called the restriction 'discriminatory and unsupported by science', and Kinshasa is negotiating an early lift , but the administration has historically treated border-based health measures as a political signal rather than an epidemiological tool.

Key tension: Whether the PABS annex deadlock at IGWG7 , with DRC sharing pathogen sequence data in real time while receiving no guaranteed vaccine access in return , will be made acutely visible to high-income bloc negotiators by the simultaneous US entry ban on DRC nationals, creating the political conditions for a compromise, or whether the two tracks remain decoupled.

First Reported In

Update #6 · Ebola outbreak gets an R0, and a fork

World Health Organization· 9 Jun 2026

Read original →

Causes and effects

Caused by

US bans entry from DRC, Uganda, S Sudan

HHS expanded the 18 May entry ban to cover green-card holders, widening rather than lifting the restriction ahead of its ~17 June expiry

Occurred 18 May 2026

Read story →

WHO defers vaccine-sharing pact to 2027

PABS annex deadlock at IGWG7 continues the deferral from WHA79, with the Bundibugyo outbreak now making the equity gap live

Occurred 19 May 2026

Read story →

This Event

US widens Ebola ban to green-card holders

The equity gap the PABS annex exists to close is running live in DRC, which is sharing pathogen data in real time while receiving no guaranteed access to what that data helps produce.

Led to

US Ebola entry ban nears expiry

The unresolved US entry ban approaching expiry (event 6) directly escalates from the HHS expansion to green-card holders on 5 June.

Occurred 15 Jun 2026

Read story →

Different Perspectives

Indian Council of Medical Research

ICMR deployed a team to Kerala within hours of the 11 June Nipah confirmation in Kozhikode, tracing roughly 100 contacts including 58 healthcare workers; three days without fresh positives suggest containment of a pathogen with no licensed vaccine and a case-fatality rate of 40 to 75 percent.

ECDC / European Union

ECDC's Week 23 Communicable Disease Threats Report carried four simultaneous non-Ebola signals including the first peer-reviewed evidence of Dermatophilus congolensis sexual transmission, local mpox clade Ib European spread, and the Dermatophilus rapid risk assessment due 23 June. European import risk for Bundibugyo is assessed as very low.

United States (HHS / State Department)

Washington committed $270 million bilaterally to the response on 12 June while its 30-day entry ban on DRC, Uganda and South Sudan nationals, extended to green-card holders on 5 June, expired around 17 June unresolved. The CDC's R0=2.51 modelling is the sharpest analytical contribution to the response from any national agency.

World Health Organization

DON607's publication on 13 June provides the 695-case international reference and attributes the treatment trial design to national leadership rather than WHO advisory consensus; the WHO co-authors the Continental Strategic Plan with Africa CDC but holds no enforcement lever over the US entry ban expiring 17 June.

Uganda Ministry of Health

Diana Atwine's ministry traced the 14-imported-case Uganda cluster using protocols rehearsed in the 2022 Sudan ebolavirus containment of 142 cases in 113 days; Uganda co-authorises the treatment trial and Bwera border lab reduces cross-border confirmation to same-day. Nineteen confirmed cases with five from onward Kampala transmission test whether the Sudan playbook transfers.

DRC Ministry of Health

Kinshasa's 14 June bulletin counted 782 confirmed cases with 45.9 percent isolated, a figure DRC's health minister has linked directly to ongoing attacks on treatment facilities rather than community resistance. DRC co-leads the clinical trial now under national authority, a regulatory posture that keeps Geneva's timeline advisory, not binding.